Regulation, structure, and activity of the Pseudomonas aeruginosa MexXY efflux system
Antimicrobial Agents and Chemotherapy · 07.05.2025 · 69 (5)
DOI: 10.1128/aac.01825-24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 07.05.2025. Verfasst von Logan G Kavanaugh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
The current crisis in bacterial antibiotic resistance can be attributed to the overuse (or misuse) of these essential medicines in healthcare and agriculture, coupled with the slowed progression of new drug development. In the versatile, opportunistic pathogen Pseudomonas aeruginosa , the Resistance-Nodulation-Division (RND) efflux pump MexXY plays critical roles in both cell physiology and the acquisition of multidrug resistance. The mexXY operon is not constitutively expressed, but this process is instead controlled by a complex network of multiple interconnected regulatory mechanisms. These include induction by several of the pump’s ribosome-targeting antibiotic substrates and transcriptional repression and anti-repression processes that are themselves influenced by various cellular factors, processes, or stresses. Although extensive studies of the MexXY complex are currently lacking as compared to other RND efflux pumps such as Escherichia coli AcrAB-TolC, recent studies have provided valuable insights into the MexXY architecture and substrate profiles, including its contribution to clinical resistance. Furthermore, while MexXY primarily associates with the outer membrane protein OprM, emerging evidence suggests that this transporter-periplasmic adaptor pair may also partner with other outer membrane proteins, potentially to alter the efflux substrate profile and activity under specific environmental conditions. In this minireview, we summarize current understanding of MexXY regulation, structure, and substrate selectivity within the context of clinical resistance and as a framework for future efflux pump inhibitor development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA.
- Graduate Program in Microbiology and Molecular Genetics, Emory University, Atlanta, Georgia, USA.
- Department of Chemistry, Emory University, Atlanta, Georgia, USA.
- Graduate Program in Biochemistry, Cell and Developmental Biology, Emory University, Atlanta, Georgia, USA.
- Emory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, Georgia, USA.
ORCID-Profile: Logan G Kavanaugh, Christine M Dunham, Graeme L Conn
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of General Medical Sciences
- Burroughs Wellcome Fund
Zitieren
APA
Kavanaugh, L. G., Hinrichsen, M. E., Dunham, C. M., & Conn, G. L. (2025). Regulation, structure, and activity of the Pseudomonas aeruginosa MexXY efflux system. Antimicrobial Agents and Chemotherapy, 69(5). https://doi.org/10.1128/aac.01825-24
Vancouver
Kavanaugh LG, Hinrichsen ME, Dunham CM, Conn GL. Regulation, structure, and activity of the Pseudomonas aeruginosa MexXY efflux system. Antimicrobial Agents and Chemotherapy. 2025;69(5). doi:10.1128/aac.01825-24
BibTeX
@article{Kavanaugh2025,
author = {Kavanaugh, Logan G and Hinrichsen, Megan E and Dunham, Christine M and Conn, Graeme L},
title = {Regulation, structure, and activity of the Pseudomonas aeruginosa MexXY efflux system},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
volume = {69},
number = {5},
doi = {10.1128/aac.01825-24}
}
EUVIMED